Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5 » default

ClinicoEconomics and Outcomes Research


Archive: Volume 5, 2013

C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia

Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C

ClinicoEconomics and Outcomes Research 2013, 5:611-621

Published Date: 3 December 2013

Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia

Liedgens H, Obradovic M, Nuijten M

ClinicoEconomics and Outcomes Research 2013, 5:597-609

Published Date: 25 November 2013

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Lensberg BR, Drummond MF, Danchenko N, Despiégel N, François C

ClinicoEconomics and Outcomes Research 2013, 5:565-573

Published Date: 18 November 2013

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy

Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M

ClinicoEconomics and Outcomes Research 2013, 5:545-553

Published Date: 18 October 2013

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL

ClinicoEconomics and Outcomes Research 2013, 5:507-517

Published Date: 24 October 2013

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines

Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G

ClinicoEconomics and Outcomes Research 2013, 5:489-496

Published Date: 3 October 2013

Cost of noninfectious comorbidities in patients with HIV

Guaraldi G, Zona S, Menozzi M, Carli F, Bagni P, Berti A, Rossi E, Orlando G, Zoboli G, Palella F

ClinicoEconomics and Outcomes Research 2013, 5:481-488

Published Date: 23 September 2013

Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device

Grabner M, Chen Y, Nguyen M, Abbott SD, Quimbo R

ClinicoEconomics and Outcomes Research 2013, 5:471-479

Published Date: 23 September 2013

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

O'Day K, Rajagopalan K, Meyer K, Pikalov A, Loebel A

ClinicoEconomics and Outcomes Research 2013, 5:459-470

Published Date: 13 September 2013

Early enteral nutrition in critical illness: a full economic analysis using US costs

Doig GS, Chevrou-Séverac H, Simpson F

ClinicoEconomics and Outcomes Research 2013, 5:429-436

Published Date: 23 August 2013

Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study

Sicras-Mainar A, Díaz-Cerezo S, Sanz de Burgoa V, Navarro-Artieda R

ClinicoEconomics and Outcomes Research 2013, 5:419-427

Published Date: 19 August 2013

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy

Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H

ClinicoEconomics and Outcomes Research 2013, 5:407-418

Published Date: 14 August 2013

Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study

Bank AJ, Obetz C, Konrardy A, Khan A, Pillai KM, McKinley BJ, Gage RM, Turnbull MA, Kenney WO

ClinicoEconomics and Outcomes Research 2013, 5:399-406

Published Date: 9 August 2013

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B

ClinicoEconomics and Outcomes Research 2013, 5:355-367

Published Date: 11 July 2013

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Henk HJ, Chen C, Benedict A, Sullivan J, Teitelbaum A

ClinicoEconomics and Outcomes Research 2013, 5:347-354

Published Date: 9 July 2013

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Darbà J, Pérez-Álvarez N, Kaskens L, Holgado-Pérez S, Racketa J, Rejas J

ClinicoEconomics and Outcomes Research 2013, 5:327-336

Published Date: 5 July 2013

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Borghi C, Ambrosioni E, Omboni S, Cicero AFG, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D

ClinicoEconomics and Outcomes Research 2013, 5:317-325

Published Date: 8 July 2013

A cost-of-illness study of spina bifida in Italy

Colombo GL, Di Matteo S, Vinci M, Gatti C, Pascali MP, De Gennaro M, Macrellino E, Mosiello G, Redaelli T, Schioppa F, Dieci C

ClinicoEconomics and Outcomes Research 2013, 5:309-316

Published Date: 2 July 2013

The costs of traumatic brain injury: a literature review

Humphreys I, Wood RL, Phillips CJ, Macey S

ClinicoEconomics and Outcomes Research 2013, 5:281-287

Published Date: 26 June 2013

The clinical and economic burden of chronic obstructive pulmonary disease in the USA

Guarascio AJ, Ray SM, Finch CK, Self TH

ClinicoEconomics and Outcomes Research 2013, 5:235-245

Published Date: 17 June 2013

Medical technology as a key driver of rising health expenditure: disentangling the relationship

Sorenson C, Drummond M, Bhuiyan Khan B

ClinicoEconomics and Outcomes Research 2013, 5:223-234

Published Date: 30 May 2013

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain

Llibre JM, Cardona G, Santos JR, Andreu A , Estrada JO, Ara J, Bonafont X, Clotet B

ClinicoEconomics and Outcomes Research 2013, 5:215-221

Published Date: 23 May 2013

Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany

Klussmann JP, Schädlich PK, Chen X, Rémy V

ClinicoEconomics and Outcomes Research 2013, 5:203-213

Published Date: 16 May 2013

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

Degli Esposti L, Saragoni S, Buda S, Sturani A, Degli Esposti E

ClinicoEconomics and Outcomes Research 2013, 5:193-201

Published Date: 14 May 2013

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

Walzer S, Travers K, Rieder S, Erazo-Fischer E, Matusiewicz D

ClinicoEconomics and Outcomes Research 2013, 5:189-192

Published Date: 3 May 2013

Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States

Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S

ClinicoEconomics and Outcomes Research 2013, 5:171-180

Published Date: 23 April 2013

Update on the management of cirrhosis – focus on cost-effective preventative strategies

Neff GW, Kemmer N, Duncan C, Alsina A

ClinicoEconomics and Outcomes Research 2013, 5:143-152

Published Date: 12 April 2013

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E

ClinicoEconomics and Outcomes Research 2013, 5:125-135

Published Date: 11 April 2013

Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia

Sills ES, Chiriac L, Vaughan D, Jones CA, Salem SA

ClinicoEconomics and Outcomes Research 2013, 5:119-124

Published Date: 27 March 2013

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Mencacci C, Di Sciascio G, Katz P, Ripellino C

ClinicoEconomics and Outcomes Research 2013, 5:87-99

Published Date: 7 February 2013

Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions

Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C

ClinicoEconomics and Outcomes Research 2013, 5:69-85

Published Date: 30 January 2013

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T

ClinicoEconomics and Outcomes Research 2013, 5:49-57

Published Date: 20 January 2013

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P

ClinicoEconomics and Outcomes Research 2013, 5:29-36

Published Date: 10 January 2013

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

Reynolds MR, Nilsson J, Åkerborg Ö, Jhaveri M, Lindgren P

ClinicoEconomics and Outcomes Research 2013, 5:19-28

Published Date: 8 January 2013

Epidemiology of falls and osteoporotic fractures: a systematic review

Morrison A, Fan T, Sen SS, Weisenfluh L

ClinicoEconomics and Outcomes Research 2013, 5:9-18

Published Date: 28 December 2012